Zoetis

YTD

ALL

Trade Zoetis 24 hours a day, five days a week on Robinhood.

Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.

About ZTS

Zoetis, Inc. engages in the discovery, development, manufacture, and commercialization of medicines, vaccines, diagnostic products and services, biodevices, genetic tests, and precision animal health technology. It operates through the United States and International geographical segments.

CEO

Kristin C. Peck

CEOKristin C. Peck

Employees

14,500

Employees14,500

Headquarters

Parsippany, New Jersey

HeadquartersParsippany, New Jersey

Founded

1952

Founded1952

Employees

14,500

Employees14,500

ZTS Key Statistics

Market cap

31.35B

Market cap31.35B

Price-Earnings ratio

12.39

Price-Earnings ratio12.39

Dividend yield

2.75%

Dividend yield2.75%

Average volume

8.15M

Average volume8.15M

High today

$75.54

High today$75.54

Low today

$72.48

Low today$72.48

Open price

$73.18

Open price$73.18

Volume

4.36M

Volume4.36M

52 Week high

$161.77

52 Week high$161.77

52 Week low

$71.47

52 Week low$71.47

Stock Snapshot

As of today, Zoetis(ZTS) shares are valued at $75.54. The company's market cap stands at 31.35B, with a P/E ratio of 12.39 and a dividend yield of 2.75%.

On 2026-07-03, Zoetis(ZTS) stock moved within a range of $72.48 to $75.54. With shares now at $75.54, the stock is trading +4.2% above its intraday low and 0.0% below the session's peak.

Trading volume for Zoetis(ZTS) stock has reached 4.36M, versus its average volume of 8.15M.

The stock's 52-week range extends from a low of $71.47 to a high of $161.77.

ZTS News

TipRanks 2d

Zoetis price target lowered to $85 from $136 at Barclays

Barclays lowered the firm’s price target on Zoetis (ZTS) to $85 from $136 and keeps an Equal Weight rating on the shares. The company reported a “challenging” Q...

MarketWatch 2d

Zoetis Inc. stock underperforms Tuesday when compared to competitors - MarketWatch

...

TipRanks 3d

Zoetis: Buy Rating Reaffirmed as Analyst Cuts Target to $104 but Sees Undervalued Long-Term Growth

Steve Scala, an analyst from TD Cowen, maintained the Buy rating on Zoetis. The associated price target was lowered to $104.00. End of Quarter Sale - 70% Off Un...

Analyst ratings

52%

of 21 ratings

Buy

52.4%

Hold

47.6%

Sell

More ZTS News

Simply Wall St 4d

Zoetis Joins The Russell Midcap, Is The Stock Cheap Now?

Advertisement Index reshuffle puts Zoetis in the midcap spotlight Zoetis (ZTS) is back in focus after being added to the Russell Midcap Index and related styl...

Simply Wall St 7d

Should Investor Lawsuits Over Safety, Competition, and Demand Disclosures Reshape How Zoetis Is Viewed?

In the past year, multiple law firms filed securities class action lawsuits against Zoetis, alleging that management issued misleading statements about competit...

People also own

Based on the portfolios of people who own ZTS. This list is generated using Robinhood data, and it’s not a recommendation.

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.